The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

The following is a summary of "Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies," ...

Yemaachi Biotech, a pioneering genomics research company based in Ghana, announced today a partnership with Roche to launch ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

Potential anti-tumor therapies remain to be discovered in cancer cell line high-throughput screening datasets. Here, the authors develop a machine learning approach to infer cancer cell drug ...

Cancer treatment merits a deeper, relentless probe through a proper assessment of the immunological status and genomic ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Serum biomarkers in metastatic castration-resistant prostate cancer (mCRPC) patients receiving [177Lu]Lu-PSMA-617 therapy: Post hoc analysis of a phase II clinical trial. Individual patient data (IPD) ...

Equal-depth sequencing of white blood cells (WBC) and plasma from prostate cancer (PCa) liquid biopsies (LBx) and association with clonal hematopoiesis (CH) confounders in clinically relevant genes.